Zynex Stock

Zynex EBIT

Delisted·Dec 23, 2025

The EBIT of Zynex (ZYXI) as of Aug 25, 2026 is 5.99 M USD. In the previous year, EBIT was 11.60 M USD — a change of -48.38% (lower).

EBIT

5.99 MUSD

YoY

-48.38%

Last updated:

In 2026, Zynex's EBIT was 5.99 M USD, a -48.38% increase from the 11.60 M USD EBIT recorded in the previous year.

The Zynex EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
22.94 M USD
Jan 1, 2023
11.60 M USD
Jan 1, 2024
5.99 M USD
Jan 1, 2025 (e)
10.05 M USD
Jan 1, 2026 (e)
11.07 M USD
Jan 1, 2027 (e)
12.16 M USD
Jan 1, 2028 (e)
13.32 M USD
Jan 1, 2029 (e)
14.58 M USD
The Zynex EBIT history
YEAREBITYoY
est14.58 MUSD+9.45%
est13.32 MUSD+9.54%
est12.16 MUSD+9.78%
est11.07 MUSD+10.24%
est10.05 MUSD+67.71%
5.99 MUSD-48.38%
11.60 MUSD-49.42%
22.94 MUSD+2.56%
22.37 MUSD+118.23%
10.25 MUSD-7.38%
11.07 MUSD+6.71%
10.37 MUSD+15.94%
8.94 MUSD+1,951.38%
436,000.00USD-117.57%
-2.48 MUSD-56.45%
-5.70 MUSD-25.04%
-7.60 MUSD-377.68%
2.74 MUSD-11.74%
3.10 MUSD+98.65%
1.56 MUSD-59.07%
3.81 MUSD+1,133.54%
309,176.00USD-90.22%
3.16 MUSD-1,985.57%
-167,712.00USD-2,717.23%
6,408.00USD
Access this data via the Eulerpool API

Zynex Revenue

Zynex Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
158.17 M USD
22.94 M USD
17.05 M USD
Jan 1, 2023
184.32 M USD
11.60 M USD
9.73 M USD
Jan 1, 2024
192.35 M USD
5.99 M USD
2.99 M USD
Jan 1, 2025 (e)
91.80 M USD
10.05 M USD
-41.33 M USD
Jan 1, 2026 (e)
101.20 M USD
11.07 M USD
-14.59 M USD
Jan 1, 2027 (e)
111.10 M USD
12.16 M USD
-11.85 M USD
Jan 1, 2028 (e)
121.70 M USD
13.32 M USD
-8.51 M USD
Jan 1, 2029 (e)
133.20 M USD
14.58 M USD
-3.95 M USD

Zynex Margins

Zynex stock margins

The Zynex margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Zynex. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Zynex.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
79.77 %
14.50 %
10.78 %
Jan 1, 2023
79.19 %
6.29 %
5.28 %
Jan 1, 2024
79.50 %
3.11 %
1.56 %
Jan 1, 2025 (e)
79.50 %
10.94 %
-45.02 %
Jan 1, 2026 (e)
79.50 %
10.94 %
-14.41 %
Jan 1, 2027 (e)
79.50 %
10.94 %
-10.67 %
Jan 1, 2028 (e)
79.50 %
10.94 %
-6.99 %
Jan 1, 2029 (e)
79.50 %
10.94 %
-2.97 %

Zynex Stock analysis

What does Zynex do? Zynex Inc is an American company that manufactures and distributes medical devices and accessories. The company was founded in 1996 and is headquartered in Englewood, Colorado. In recent years, it has become a major player in the pain therapy market. The history of Zynex began with the development of a neurotherapeutic system called NeuroMove, which aimed to restore mobility in patients with paralysis after strokes or other neurological disorders. The company uses proprietary technology to provide safe and effective electrotherapeutic stimulation, which helps trigger muscle contractions and improve mobility. Over the years, the company has specialized in the development and sale of medical devices for pain therapy and rehabilitation. Zynex's products can be used in various areas, including electrostimulation, TENS and EMS therapy, home diagnostics, as well as blood pressure and oxygen measurement. Zynex offers devices specifically for pain therapy. These devices are used by many doctors and physiotherapists to support patients in their healing process. The company's flagship product is the Nexus D-11 EMS and TENS device, which is capable of conducting multiple pain treatments simultaneously. Another important device from Zynex is the InWave system, which applies FDA-approved electromagnetic wave therapy. The therapy is used for both acute and chronic pain and aims to promote the body's natural healing processes to relieve pain. Zynex also manufactures home diagnostic devices such as the blood sugar monitor and pulse oximeter, which can be regularly used by patients at home to monitor their well-being. These products help individuals develop an understanding of how their body responds to different treatments or environmental conditions. An important aspect of Zynex's business model is collaborating with healthcare customers. The company forms partnerships with medical facilities and practitioners to ensure that its products are effectively and safely utilized. These partnerships often include training programs to ensure that users of each device develop a basic understanding of how it works to ensure quality treatment. Zynex has also established a subsidiary called Zynex Medical Europe, which operates in European regions. The company is based in the Netherlands and is responsible for marketing and distributing Zynex's products in Europe. Overall, Zynex has established itself as a key player in the field of pain therapy and rehabilitation. Through its innovative technology and healthcare partnerships, the company is able to provide the best possible patient care. Zynex is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Zynex's EBIT

Zynex's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Zynex's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Zynex's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Zynex’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Zynex stock

EBIT of Zynex is 5.99 M USD in 2026.

EBIT of Zynex changed from 11.60 M USD to 5.99 M USD, representing a -48.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Zynex since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Zynex historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Zynex

All Key Metrics — Zynex